IGF2 and early-onset autosomal dominant Alzheimer disease: IGF2, a pleiotropic polypeptide abundantly expressed in CNS, influences neurogenesis and neuroinflammation, with dysregulated expression linked to CNS disorders such as anxiety and Alzheimer's disease 44-46.